Authors:
COLEMAN DC
RINALDI MG
HAYNES KA
REX JH
SUMMERBELL RC
ANAISSIE EJ
LI A
SULLIVAN DJ
Citation: Dc. Coleman et al., IMPORTANCE OF CANDIDA SPECIES OTHER THAN CANDIDA-ALBICANS AS OPPORTUNISTIC PATHOGENS, MEDICAL MYCOLOGY, 36, 1998, pp. 156-165
Authors:
MASCARENAS CA
HARDIN TC
PENNICK GJ
RINALDI MG
GRAYBILL JR
Citation: Ca. Mascarenas et al., TREATMENT OF THRUSH WITH ITRACONAZOLE SOLUTION - EVIDENCE FOR TOPICALEFFECT, Clinical infectious diseases, 26(5), 1998, pp. 1242-1243
Authors:
REVANKAR SG
DIB OP
KIRKPATRICK WR
MCATEE RK
FOTHERGILL AW
RINALDI MG
REDDING SW
PATTERSON TF
Citation: Sg. Revankar et al., CLINICAL-EVALUATION AND MICROBIOLOGY OF OROPHARYNGEAL INFECTION DUE TO FLUCONAZOLE-RESISTANT CANDIDA IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS, Clinical infectious diseases, 26(4), 1998, pp. 960-963
Authors:
FURUKAWA H
KUSNE S
SUTTON DA
MANEZ R
CARRAU R
NICHOLS L
ABUELMAGD K
SKEDROS D
TODO S
RINALDI MG
Citation: H. Furukawa et al., ACUTE INVASIVE SINUSITIS DUE TO TRICHODERMA-LONGIBRACHIATUM IN A LIVER AND SMALL-BOWEL TRANSPLANT RECIPIENT, Clinical infectious diseases, 26(2), 1998, pp. 487-489
Authors:
PRZYKUCKI JM
SADKOWSKI L
THOMPSON C
RINALDI MG
PATTERSON JE
Citation: Jm. Przykucki et al., COMPARISON OF FLOOR BUFFERS AS A SOURCE OF AEROSOLIZATION OF FUNGAL SPORES IN A BONE-MARROW TRANSPLANT UNIT (BMTU), Infection control and hospital epidemiology, 19(9), 1998, pp. 5-5
Authors:
PFALLER MA
MESSER SA
HOUSTON A
RANGELFRAUSTO MS
WIBLIN T
BLUMBERG HM
EDWARDS JE
JARVIS W
MARTIN MA
NEU HC
SAIMAN L
PATTERSON JE
DIBB JC
ROLDAN CM
RINALDI MG
WENZEL RP
Citation: Ma. Pfaller et al., NATIONAL EPIDEMIOLOGY OF MYCOSES SURVEY - A MULTICENTER STUDY OF STRAIN VARIATION AND ANTIFUNGAL SUSCEPTIBILITY AMONG ISOLATES OF CANDIDA SPECIES, Diagnostic microbiology and infectious disease, 31(1), 1998, pp. 289-296
Authors:
SHIN JH
LEE SK
SUH SP
RYANG SW
KIM NH
RINALDI MG
SUTTON DA
Citation: Jh. Shin et al., FATAL HORMONEMA-DEMATIOIDES PERITONITIS IN A PATIENT ON CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS - CRITERIA FOR ORGANISM IDENTIFICATION AND REVIEW OF OTHER KNOWN FUNGAL ETIOLOGIC AGENTS, Journal of clinical microbiology, 36(7), 1998, pp. 2157-2163
Authors:
KIRKPATRICK WR
MCATEE RK
REVANKAR SG
FOTHERGILL AW
MCCARTHY DI
RINALDI MG
PATTERSON TF
Citation: Wr. Kirkpatrick et al., COMPARATIVE-EVALUATION OF NATIONAL COMMITTEE FOR CLINICAL LABORATORY STANDARDS BROTH MACRODILUTION AND AGAR DILUTION SCREENING METHODS FOR TESTING FLUCONAZOLE SUSCEPTIBILITY OF CRYPTOCOCCUS-NEOFORMANS, Journal of clinical microbiology, 36(5), 1998, pp. 1330-1332
Citation: Da. Sutton et al., US CASE-REPORT OF CEREBRAL PHEOHYPHOMYCOSIS CAUSED BY RAMICHLORIDIUM-OBOVOIDEUM (R-MACKENZIEI) - CRITERIA FOR IDENTIFICATION, THERAPY, AND REVIEW OF OTHER KNOWN DEMATIACEOUS NEUROTROPIC TAXA, Journal of clinical microbiology, 36(3), 1998, pp. 708-715
Authors:
IWEN PC
RUPP ME
BISHOP MR
RINALDI MG
SUTTON DA
TARANTOLO S
HINRICHS SH
Citation: Pc. Iwen et al., DISSEMINATED ASPERGILLOSIS CAUSED BY ASPERGILLUS-USTUS IN A PATIENT FOLLOWING ALLOGENEIC PERIPHERAL STEM-CELL TRANSPLANTATION, Journal of clinical microbiology (Print), 36(12), 1998, pp. 3713-3717
Authors:
KIRKPATRICK WR
TURNER TM
FOTHERGILL AW
MCCARTHY DI
REDDING SW
RINALDI MG
PATTERSON TF
Citation: Wr. Kirkpatrick et al., FLUCONAZOLE DISK DIFFUSION SUSCEPTIBILITY TESTING OF CANDIDA SPECIES, Journal of clinical microbiology (Print), 36(11), 1998, pp. 3429-3432
Authors:
KIRKPATRICK WR
REVANKAR SG
MCATEE RK
LOPEZRIBOT JL
FOTHERGILL AW
MCCARTHY DI
SANCHE SE
CANTU RA
RINALDI MG
PATTERSON TF
Citation: Wr. Kirkpatrick et al., DETECTION OF CANDIDA-DUBLINIENSIS IN OROPHARYNGEAL SAMPLES FROM HUMANIMMUNODEFICIENCY VIRUS-INFECTED PATIENTS IN NORTH-AMERICA BY PRIMARY CHROMAGAR CANDIDA SCREENING AND SUSCEPTIBILITY TESTING OF ISOLATES, Journal of clinical microbiology, 36(10), 1998, pp. 3007-3012
Citation: Sg. Revankar et al., INTERPRETATION OF TRAILING END-POINTS IN ANTIFUNGAL SUSCEPTIBILITY TESTING BY THE NATIONAL COMMITTEE FOR CLINICAL LABORATORY STANDARDS METHOD, Journal of clinical microbiology, 36(1), 1998, pp. 153-156
Authors:
CHAPMAN SW
ROGERS PD
RINALDI MG
SULLIVAN DC
Citation: Sw. Chapman et al., SUSCEPTIBILITIES OF CLINICAL AND LABORATORY ISOLATES OF BLASTOMYCES-DERMATITIDIS TO KETOCONAZOLE, ITRACONAZOLE, AND FLUCONAZOLE, Antimicrobial agents and chemotherapy, 42(4), 1998, pp. 978-980
Authors:
ODDS FC
VANGERVEN F
ESPINELINGROFF A
BARTLETT MS
GHANNOUM MA
LANCASTER MV
PFALLER MA
REX JH
RINALDI MG
WALSH TJ
Citation: Fc. Odds et al., EVALUATION OF POSSIBLE CORRELATIONS BETWEEN ANTIFUNGAL SUSCEPTIBILITIES OF FILAMENTOUS FUNGI IN-VITRO AND ANTIFUNGAL TREATMENT OUTCOMES IN ANIMAL INFECTION MODELS, Antimicrobial agents and chemotherapy, 42(2), 1998, pp. 282-288
Authors:
NGUYEN MH
CLANCY CJ
YU VL
YU YC
MORRIS AJ
SNYDMAN DR
SUTTON DA
RINALDI MG
Citation: Mh. Nguyen et al., DO IN-VITRO SUSCEPTIBILITY DATA PREDICT THE MICROBIOLOGIC RESPONSE TOAMPHOTERICIN-B - RESULTS OF A PROSPECTIVE-STUDY OF PATIENTS WITH CANDIDA-FUNGEMIA, The Journal of infectious diseases, 177(2), 1998, pp. 425-430
Citation: Sg. Revankar et al., A RANDOMIZED TRIAL OF CONTINUOUS OR INTERMITTENT THERAPY WITH FLUCONAZOLE FOR OROPHARYNGEAL CANDIDIASIS IN HIV-INFECTED PATIENTS - CLINICALOUTCOMES AND DEVELOPMENT OF FLUCONAZOLE RESISTANCE, The American journal of medicine, 105(1), 1998, pp. 7-11
Authors:
CLEARY JD
CHAPMAN SW
HARDIN TC
RINALDI MG
SPENCER JL
DENG J
PENNICK GJ
LOBB CJ
Citation: Jd. Cleary et al., AMPHOTERICIN-B ENZYME-LINKED IMMUNOASSAY FOR CLINICAL USE - COMPARISON WITH BIOASSAY AND HPLC, The Annals of pharmacotherapy, 31(1), 1997, pp. 39-44
Citation: Mr. Mcginnis et Mg. Rinaldi, SOME MEDICALLY IMPORTANT FUNGI AND THEIR COMMON SYNONYMS AND OBSOLETENAMES, Clinical infectious diseases, 25(1), 1997, pp. 15-17
Authors:
REX JH
PFALLER MA
GALGIANI JN
BARTLETT MS
ESPINELINGROFF A
GHANNOUM MA
LANCASTER M
ODDS FC
RINALDI MG
WALSH TJ
BARRY AL
Citation: Jh. Rex et al., DEVELOPMENT OF INTERPRETIVE BREAKPOINTS FOR ANTIFUNGAL SUSCEPTIBILITYTESTING - CONCEPTUAL-FRAMEWORK AND ANALYSIS OF IN-VITRO IN-VIVO CORRELATION DATA FOR FLUCONAZOLE, ITRACONAZOLE, AND CANDIDA INFECTIONS, Clinical infectious diseases, 24(2), 1997, pp. 235-247